BA
CARM

BlackRock Advisors’s Carisma Therapeutics CARM Stock Holding History

BlackRock Advisors’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,841
Closed -$273K – 3768
2015
Q2 		$273K Buy
4,841
+4,336
+859% +$612K ﹤0.01% 2604
2015
Q1 		$90K Buy
505
+409
+426% +$89.4K ﹤0.01% 3086
2014
Q4 		$23K Hold
96
– – ﹤0.01% 3472
2014
Q3 		$21K Hold
96
– – ﹤0.01% 3488
2014
Q2 		$25K Sell
96
-4,436
-98% -$1.1M ﹤0.01% 3392
2014
Q1 		$1.47M Buy
+4,532
New +$1.36M ﹤0.01% 1306

Other funds holding CARM

TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
Rotella Capital Management Bellevue, Washington $1.47M AUM 12.32% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return